NEWSKU-24-MV8P9VL8-651Z
Promed Hepatitis C Virus (HCV) Antibody Rapid Test Kit
Unit Price · Ex-Lagos
₦18,500
approx. $12.09 at today's rate
10 units available · MOQ 1 unit · Ships in 48hrs
× ₦18,500
Buyer protected Nationwide logistics Paystack verified
Fulfilled by Store
HH-00004
The Promed Hepatitis C Virus (HCV) Rapid Test Kit is a professional in-vitro diagnostic screening test designed for the qualitative detection of antibodies associated with Hepatitis C Virus infection.
The kit provides a convenient method for preliminary Hepatitis C screening in hospitals, diagnostic laboratories, clinics, health screening centres and other healthcare facilities.
Using lateral flow immunochromatographic technology, HCV antibody rapid tests detect antibodies produced by the immune system in response to exposure to Hepatitis C Virus.
The Promed HCV Rapid Test Kit supports efficient screening without the need for specialised laboratory analyzers, making it suitable for healthcare settings that require accessible and timely infectious disease testing.
The kit is intended for preliminary antibody screening. Reactive results require appropriate follow-up testing, including HCV RNA testing, to establish whether a patient has a current Hepatitis C infection.
Key Features
- Hepatitis C antibody detection: Designed for qualitative screening of antibodies against Hepatitis C Virus.
- Rapid testing: Standard HCV antibody rapid tests typically provide results within 10–20 minutes, depending on the product instructions.
- Immunochromatographic technology: Utilises a lateral flow antibody detection method.
- Simple visual results: Test and control lines support straightforward interpretation.
- No analyzer required: Suitable for settings without specialized immunoassay equipment.
- Professional use: Intended for appropriately trained healthcare personnel.
- Disposable testing format: Designed for single-use diagnostic testing.
- Infectious disease screening: Supports clinical hepatitis screening programmes.
- Convenient operation: May be used in laboratories and appropriate point-of-care settings.
- Preliminary results: Supports identification of patients requiring additional Hepatitis C investigations.
